Graham Capital Management, L.P. Care Dx, Inc. Transaction History

Graham Capital Management, L.P.

$4.38 Billion
Q1 2025

A detailed history of Graham Capital Management, L.P. transactions in Care Dx, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 25,368 shares of CDNA stock, worth $483,767. This represents 0.01% of its overall portfolio holdings.

Number of Shares

25,368

Previous 29,281 13.36%

Holding current value

$483,767

Previous $626,000 28.12%

% of portfolio

0.01%

Previous 0.01%

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$17.64 - $25.07 $69,025 - $98,098	-3,913 Reduced 13.36%	25,368 $450,000
Q4 2024 Feb 14, 2025	BUY	$20.4 - $32.2 $284,743 - $449,447	13,958 Added 91.09%	29,281 $626,000
Q3 2024 Nov 14, 2024	BUY	$14.41 - $33.99 $220,804 - $520,828	15,323 New	15,323 $478,000
Q3 2022 Nov 14, 2022	BUY	$16.06 - $26.39 $847,566 - $1.39 Million	52,775 New	52,775 $898,000

About CareDx, Inc.

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.02B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

More about CDNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.

Account

Graham Capital Management, L.P. Care Dx, Inc. Transaction History